Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cancers, 2023
Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin–Progranulin Axis in Breast Cancer

Berger K., Persson E., Gregersson P. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Scientific Data, 2023
A dataset of proteomic changes during human heat stress and heat acclimation

Gagnon D., Barry H., Barhdadi A. et al.

Olink Explore 3072/384Environmental Health & ToxicologyPathophysiologyPlasma

OncoImmunology, 2023
Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases

Li M., Chen J., Yu H. et al.

Olink Target 96OncologyPatient StratificationPlasmaCSF

Nature, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

LaMarche N., Hegde S., Park M. et al.

Olink Target 96OncologyPathophysiologySerum

JCI Insight, 2023
Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia

Englund D., Jolliffe A., Hanson G. et al.

Olink Target 96 MouseOncologyPathophysiologyMouse PlasmaCell Lysate

Clinical Cancer Research, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer

Bessede A., Peyraud F., Besse B. et al.

Olink Explore 3072/384OncologyImmunotherapyPatient StratificationPlasma

European Journal of Heart Failure, 2023
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials

Ferreira J., Butler J., Anker S. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

eBioMedicine, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

Zhang X., Irajizad E., Hoffman K. et al.

Olink Target 96OncologyNutritional SciencePathophysiologyPlasma

Scientific Reports, 2023
Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome

Goudswaard L., Smith M., Hughes D. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologySerum

Cancers, 2023
Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor

Stensgaard S., Thomsen A., Helstrup S. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Nature Communications, 2023
Plasma proteomic profiles predict individual future health risk

You J., Guo Y., Zhang Y. et al.

Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPlasma

Circulation: Genomic and Precision Medicine, 2023
Plasma Protein Profiling of Incident Cardiovascular Diseases: A Multisample Evaluation

Lind L., Titova O., Zeng R. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2023
Plasma neurofilament light levels show elevation two years prior to diagnosis of amyotrophic lateral sclerosis in the UK Biobank

Smith E., Lee J., Prilutsky D. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

ESC Heart Failure, 2023
Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure

de Bakker M., Loncq de Jong M., Petersen T. et al.

Olink Target 96CVDPathophysiologyPlasma

Journal of Thrombosis and Haemostasis, 2023
Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities

Yuan S., Xu F., Zhang H. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Pediatric Research, 2023
Antisecretory factor in breastmilk is associated with reduced incidence of sepsis in preterm infants

Gustafsson A., Johansson E., Henckel E. et al.

Olink Target 96Infectious DiseasesObstetricsPathophysiologyPlasma

Nature Communications, 2023
Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation

Mälarstig A., Grassmann F., Dahl L. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Frontiers in Immunology, 2023
Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay

Kmezic I., Gustafsson R., Fink K. et al.

Olink Target 96NeurologyPatient StratificationPlasmaCSF

iScience, 2023
Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion

Moaddel R., Farmer C., Yavi M. et al.

Olink Explore 3072/384NeurologyPathophysiologyCSF

Brain, 2023
Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains

Quesnel M., Labonté A., Picard C. et al.

Olink Target 96NeurologyPathophysiologyCSF

2996 publications